Ellen Rose
Investor Relations Contact chez LYELL IMMUNOPHARMA, INC.
Profil
Ellen Rose is currently the Senior VP-Communications & Investor Relations at Lyell Immunopharma, Inc. She previously worked as the Director-Communications at ALZA Corp.
and as the Head-Communications & Media Relations at Prothena Corp.
Plc.
Ms. Rose completed her undergraduate degree at Stanford University.
Postes actifs de Ellen Rose
| Sociétés | Poste | Début |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Investor Relations Contact | 01/04/2021 |
Anciens postes connus de Ellen Rose
| Sociétés | Poste | Fin |
|---|---|---|
| ALZA CORPORATION | Public Communications Contact | - |
| PROTHENA CORPORATION PLC | Public Communications Contact | - |
Formation de Ellen Rose
| Stanford University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
